Elutia (ELUT) Return on Capital Employed (2020 - 2026)
Elutia recorded quarterly Return on Capital Employed of 79.85% in Q1 2026, up 41.73% quarter-over-quarter from 137.04% in Q4 2025, and up 362531.0% year-over-year from N/an in Q1 2025.
Elutia's Return on Capital Employed history runs 7 years deep, the most recent figure standing at 79.85% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 362531.0% year-over-year to 79.85%; the TTM figure through Mar 2026 stood at 79.85% (up 362531.0% YoY), while the FY2025 annual figure was 111.67%, up 143749.0% from the prior year.
- Return on Capital Employed came in at 79.85% for Q1 2026 at Elutia, up from 137.04% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 2797.28% in Q2 2024 to a low of 3705.17% in Q1 2025.
- A 5-year average of 230.18% and a median of 150.55% in 2022 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed sank 215906 bps in 2024 and surged 362531 bps in 2026, its largest moves.
- Elutia's Return on Capital Employed stood at 150.55% in 2022, then sank by 240 bps to 511.6% in 2023, then sank by 47 bps to 751.83% in 2024, then surged by 82 bps to 137.04% in 2025, then soared by 42 bps to 79.85% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 79.85%, 137.04%, and 302.06% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | -79.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.85% |
| Dec 31, 2025 | -28.86% |
| Sep 30, 2025 | 313.86% |
| Jun 30, 2025 | 2,504.91% |
| Mar 31, 2025 | -3,838.07% |
| Dec 31, 2024 | -751.83% |
| Sep 30, 2024 | -632.99% |
| Jun 30, 2024 | 2,797.28% |
| Mar 31, 2024 | -2,309.26% |
| Dec 31, 2023 | -511.60% |
| Sep 30, 2023 | -361.83% |
| Jun 30, 2023 | -243.47% |
| Mar 31, 2023 | -150.20% |
| Dec 31, 2022 | -150.55% |
| Sep 30, 2022 | -189.82% |
| Jun 30, 2022 | -137.90% |
| Mar 31, 2022 | -72.47% |
| Dec 31, 2021 | -61.36% |
| Sep 30, 2021 | -45.48% |
| Jun 30, 2021 | -30.91% |
| Mar 31, 2021 | -26.27% |
| Dec 31, 2020 | -36.07% |